DUSP1 and cancer: Several studies have already shown the involvement of DUSPs as major modulators of critical signalling pathways dysregulated in different cancers [43], such as in the case of the overexpression of DUSP1/MKP-1 in the early phases of cancer and its decreasing during tumour progression [42].